Wells Fargo’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-50
| Closed | -$284 | – | 7294 |
|
|
2025
Q4 | $284 | Hold |
50
| – | – | ﹤0.01% | 6367 |
|
|
2025
Q3 | $306 | Sell |
50
-103
| -67% | -$534 | ﹤0.01% | 6325 |
|
|
2025
Q2 | $490 | Sell |
153
-2,867
| -95% | -$11K | ﹤0.01% | 6375 |
|
|
2025
Q1 | $12.2K | Sell |
3,020
-264
| -8% | -$1.85K | ﹤0.01% | 5846 |
|
|
2024
Q4 | $34.8K | Buy |
3,284
+579
| +21% | +$10.3K | ﹤0.01% | 5599 |
|
|
2024
Q3 | $66.8K | Buy |
2,705
+97
| +4% | +$2.56K | ﹤0.01% | 5235 |
|
|
2024
Q2 | $73.5K | Buy |
2,608
+571
| +28% | +$18.6K | ﹤0.01% | 5117 |
|
|
2024
Q1 | $82.9K | Buy |
2,037
+205
| +11% | +$4.83K | ﹤0.01% | 4998 |
|
|
2023
Q4 | $30.2K | Buy |
1,832
+456
| +33% | +$7.95K | ﹤0.01% | 5468 |
|
|
2023
Q3 | $52.2K | Sell |
1,376
-564
| -29% | -$26.7K | ﹤0.01% | 5158 |
|
|
2023
Q2 | $107K | Buy |
1,940
+875
| +82% | +$40.2K | ﹤0.01% | 4994 |
|
|
2023
Q1 | $45.8K | Buy |
1,065
+855
| +407% | +$41.4K | ﹤0.01% | 5202 |
|
|
2022
Q4 | $8.25K | Sell |
210
-12
| -5% | -$630 | ﹤0.01% | 5623 |
|
|
2022
Q3 | $12K | Sell |
222
-45
| -17% | -$2.81K | ﹤0.01% | 5610 |
|
|
2022
Q2 | $18K | Sell |
267
-344
| -56% | -$22.5K | ﹤0.01% | 5503 |
|
|
2022
Q1 | $45K | Sell |
611
-1,400
| -70% | -$81.1K | ﹤0.01% | 5705 |
|
|
2021
Q4 | $143K | Buy |
2,011
+1,942
| +2,814% | +$339K | ﹤0.01% | 5448 |
|
|
2021
Q3 | $17K | Buy |
69
+50
| +263% | +$12K | ﹤0.01% | 6019 |
|
|
2021
Q2 | $5K | Sell |
19
-316
| -94% | -$94.5K | ﹤0.01% | 6337 |
|
|
2021
Q1 | $95K | Sell |
335
-362
| -52% | -$116K | ﹤0.01% | 5511 |
|
|
2020
Q4 | $198K | Sell |
697
-243
| -26% | -$78K | ﹤0.01% | 5092 |
|
|
2020
Q3 | $291K | Buy |
+940
| New | +$225K | ﹤0.01% | 4740 |
|
Other funds holding GBIO
Wells Fargo's GBIO Position: Q1 2026 in Review
Wells Fargo sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 50 shares — an estimated $284 sold.
Wells Fargo first reported a position in GBIO in Q3 2020 and held it in 22 quarters. The position peaked at $291K in Q3 2020. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Wells Fargo reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Wells Fargo sold 50 Generation Bio shares in Q1 2026, an estimated $284.
- Wells Fargo first reported a position in Generation Bio in Q3 2020 and held it in 22 quarters.
- Wells Fargo's Generation Bio position peaked at $291K in Q3 2020.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.